Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by mercedesmanon Nov 23, 2020 1:31pm
147 Views
Post# 31953502

RE:Dr. Shaf Keshavjee (UHN) - "This is Real"

RE:Dr. Shaf Keshavjee (UHN) - "This is Real" What is REAL is that  SQI and the Shaf are about to launch a new frontier in medicine (vastly increasing the success rate of organ transplantation the world over)

And we are trading at a mere $ 79M CAD Market Cap  ($ 60 M USD)


That piece alone is probably worth $ 100M valuation.


Add Covid triage tool (proper allocation of billions in over-run ICU resources)

Add Covid in-depth analysis (decide who needs/gets the expensive and needed treatments)

Add D2C Covid Antibody (high accuracy)  Do you have it without waiting in long car line-ups, and or if already have it - and your level of protection?

On top of two other D2C diagnositics (RA, and Celiac) - which will get more attention now, given Covid D2C once unveiled.

and

$ 1/2 B USD is not out of the question in today's BioTech market ( = 8X current valuation = $ 2/sh)

glta

MM



<< Previous
Bullboard Posts
Next >>